Introduction

Heparin is a blood thinner or an anticoagulant i.e. which is responsible for preventing blood clots formation. It is usually used in treatment of blood clot in heart, veins or lungs. They are generally used before surgical procedure, at the time of dialysis or when blood is taken for sampling mostly during blood transfusion. Apart from this it is also used to treat various blood clot disorders. In pharmaceuticals, type of heparin used is from meat of specific animal’s body parts such as cattle’s lungs and pig’s intestine which is derived from specific mucosal tissues. Heparin is injected in the vein or under the skin but not into the muscle and amount of dose depends upon the response to treatment, the weight and patient’s medical condition. Heparin is available in multiple ranges, and as it may also cause fatal injuries, hence, extreme precaution should be taken. The regular use of heparin could help in distributing best results.

Market Dynamics

Heparin gel used as lithium salt and it is applied in test tubes as anticoagulant. It also has applications for treating sports injuries; heparin-coated blood oxygenators heart diseases, and for protein purification immobilized heparin are commonly used. In addition, global aging problem and increasing focus on advancement for research and development initiatives by various drug manufactures are basic drivers for the heparin market. However, due to easy bleeding, pain, irritation, redness, warmth or skin changes where the heparin was injected or bluish-colored skin at the applied area are some challenges hampers the widespread adoption by end-users.  Escalating healthcare expenditure by developed and developing countries in offers key opportunities for growth in forthcoming years.

Market Classification

The market can be bifurcated on the basis of product type, source, formulation, and geography. By product type, heparin market can be segmented into unfractionated heparin (UFH), low-molecular weight heparin (LMWH), ultra-low molecular weight heparin (ULMWH). By source, heparin market can be segmented into bovine and, porcine. By formulation, heparin market can be segmented into oral and parenteral.On the basis of geography, the heparin Market can be segmented into North America, Latin America, Europe, Middle East & Africa (MEA) and Asia-Pacific.

Report Coverage

Market	Heparin Market
Analysis Period	2015 – 2026
Historic Data	2015 – 2016
Base Year	2017
Forecast Data	2018 – 2026
Market Stratification	Product Type, Source, Formulation, Geography
Regional Scope	North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)
Report Coverage	Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis, Player Profiling, Value Chain Analysis

Market Participants

Some of the major players involved in heparin market include

• GlaxoSmithKline PLC
• Pfizer Inc.
• Baxter Healthcare
• Shandong East Chemical Industry Co
• Bristol-Myers Squibb Co.
• Leo Pharma Inc.
• Sanofi S.A.
• Hisunny Chemical Co
• Leap Labchem Co. Ltd
• Others

Market Segmentation

Market By Product Type

• Unfractionated Heparin (UFH)
• Low-Molecular Weight Heparin (LMWH)
• Ultra-Low Molecular Weight Heparin (ULMWH)

Market By Source

• Bovine
• Porcine

Market By Formulation

• Oral
• Parenteral

Market By Geography

North America

• U.S.
• Canada
• Mexico

Europe

• UK
• France
• Germany
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Australia
• Rest of Asia-Pacific

Latin America

• Brazil
• Chile
• Rest of LATAM

Middle East and Africa (MEA)

• South Africa
• Saudi Arabia
• Rest of MEA

TABLE OF CONTENT